BioMed 21 is a bold Washington University initiative dedicated to translating basic science discoveries into solutions for the world's biggest health problems.
Our Approach
Through its Interdisciplinary Research Centers (IRCs) and Cornerstone Centers, BioMed 21 promotes collaborative, strategically targeted basic science.
LEARN ABOUT CORNERSTONES
LEARN ABOUT IRCs

-
Collaborate and share resources
To carry out its mission, BioMed 21 has established seven Interdisciplinary Research Centers (IRCs), which conduct disease-focused basic science in large, multidisciplinary teams. Three Cornerstone Centers augment the IRCs' efforts through shared technology, expertise and training, and also conduct their own research.
-
Focus efforts strategically
Each IRC focuses on a specific area of medicine. Collectively, they target the world's major diseases, fueling Washington University's commitment to addressing mankind's greatest health problems, both in our local community and worldwide.
-
Study disease at its source
The IRCs seek to understand the fundamental biological malfunctions that cause disease. For biggest impact, many focus on issues that underlie entire disease families, with the goal of devising solutions that can be applied broadly.
-
Translate knowledge into solutions
As they uncover the root causes of disease, the IRCs are applying this powerful knowledge to develop ways to diagnose earlier and more accurately, tailor treatment to the individual and prevent disease effectively.
-
Apply solutions broadly
BioMed 21's task is complex, but the payoff is staggering. We stand on the brink of transforming the very meaning of medicine — moving from treating symptoms of disease to arresting disease at its very root and even preventing illness altogether.


Our Priorities
BioMed 21 takes aim at the world's most important diseases.
LEARN MORE ABOUT BIOMED 21
The Brain
Cancer and Personalized Medicine
Diabetes, Heart Disease and Obesity
Infectious Diseases and Global Health
Women's and Children's Health
The Brain
BioMed 21 scientists seek to understand and address underlying processes of brain injury and disease. The ultimate goal: Find ways to diagnose early, treat effectively, and in some cases, prevent altogether. Among the targets: Alzheimer's disease, ALS, brain trauma, epilepsy, stroke and depression.
IRCs Involved
The BRIGHT Institute
Center for Genome Sciences & Systems Biology
Center for the Investigation of Membrane Excitability Diseases
Center for Study of Itch
Center for Women's Infectious Disease Research
Diabetic Cardiovascular Disease Center
Hope Center Program on Protein Aggregation and Neurodegeneration
Cornerstones Involved
Center for Clinical Imaging
Research
The Genome Institute
Institute of Clinical and Translational Sciences
News
September 23, 2012
Some deadly breast cancers share genetic features with ovarian tumors »
September 17, 2012
